China's Booming Beauty Industry Spurs Demand for Medical-Grade Aesthetic Consumables

✅ News Report:

China’s beauty industry is undergoing a high-tech transformation, fueled by the rapid growth of the “appearance economy” and evolving consumer preferences. By 2024, the national beauty market surpassed 800 billion yuan (USD 110 billion), with medical aesthetics emerging as the strongest growth sector, reaching over 350 billion yuan and growing at a 26.1% compound annual rate.

One of the most promising segments is aesthetic medical consumables, including dermal fillers, injectable solutions, threads, and microneedling supplies. These products are now a core focus of capital investment and industrial expansion.

✅ Key Highlights & Examples:

• Capital Rush: In 2024, more than 30 major financing rounds in aesthetic medical devices and consumables surpassed 1 billion yuan each. Investment is flowing into HA fillers, bioactive materials, and smart injectable devices.

• Domestic Innovation:

  • Bloomage BioTech and IMEIK Technology now dominate over 58% of China’s HA filler market, with differentiated brands such as “Girl Needles” and “Rubi Angel” offering improved comfort and retention.

  • Pechoin, a traditional skincare brand, has entered the Class II medical device market by launching a medical aesthetics division, marking a shift from cosmetic to clinical skincare.

• Clinic Expansion: Over 18,500 certified medical aesthetic clinics operate across China as of 2023, with major expansions seen in cities like Beijing, Shanghai, and Chengdu.

✅Why the Surge in Demand for Consumables?

• Young Consumer Base: Over 62% of medical aesthetics users are Gen Z and post-95s, spending up to ¥28,000 per year, with male consumers growing at 38% annually.

• Technology-Driven Care: AI-assisted facial analysis, synthetic biomaterials, and personalized injection systems are driving product differentiation and professionalization.

• Stricter Regulation: China has improved compliance standards and product registration for injectable devices and materials, aligning with international regulations and favoring certified suppliers.

✅ Industry Outlook:

• Continued Market Expansion: China's aesthetic medicine market is expected to exceed ¥350 billion by 2025, with a CAGR of over 15% in the next five years.

• Globalization & Premiumization: Chinese brands are enhancing R&D to compete globally, while multinational companies are expanding localized production in China.

• Full-Spectrum Integration: From raw materials and OEM consumables to clinical applications, the supply chain is becoming more complete and standardized, pushing the industry toward high-quality, sustainable growth.

China's beauty and aesthetic medicine industry is no longer just about skincare and makeup. Medical-grade consumables are now at the forefront, transforming how beauty is delivered — from beauty salons to regulated clinical institutions. The industry’s next phase will be defined by technology, safety, personalization, and international expansion.

Would you like this formatted for a company newsletter or press release?